← Back to headlines
Pulmonx Outlines 2026 Revenue Target and Cost Realignment
Pulmonx has set a 2026 revenue target of $90M-$92M, accompanied by a cost realignment strategy and a renewed focus on U.S. sales to achieve its financial goals.
5 Mar, 01:02 — 5 Mar, 01:02
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
74 Companies Pointed Out for Hiding Income, Remitting Funds to Hong Kong for Kickbacks, Says National Tax Agency
9m ago
Bessent says new global tariff will likely increase to 15% from 10% 'sometime this week'
9m ago
US Federal Reserve warns of economic uncertainty due to Trump's tariffs
12m ago
China Sets Lowest Economic Growth Target in Decades
15m ago